Retinoblastoma is a rare but highly treatable form of eye cancer that primarily affects young children, often under the age of 5. It originates in the retina, the light-sensitive layer at the back of the eye responsible for transmitting visual information to the brain. Retinoblastoma is caused by mutations in the RB1 gene, which is a tumor suppressor gene that normally helps regulate cell growth. When this gene is mutated or deleted, it can lead to the uncontrolled growth of retinal cells, resulting in a tumor.

Types of Retinoblastoma

1. Hereditary Retinoblastoma:
   • This form accounts for about 40% of cases and is inherited in an autosomal dominant manner. Children with hereditary retinoblastoma inherit one mutated copy of the RB1 gene from a parent. The second mutation occurs in a retinal cell during development, leading to the formation of a tumor.
   • Children with hereditary retinoblastoma are at increased risk of developing bilateral (both eyes) tumors and may also be at risk for other cancers later in life.
2. Non-Hereditary (Sporadic) Retinoblastoma:
   • In sporadic retinoblastoma, both mutations of the RB1 gene occur in a single retinal cell, and there is no family history of the disease. This form typically presents with unilateral (one eye) tumors, and the risk of developing other cancers is not elevated as it is with hereditary cases.

Symptoms of Retinoblastoma

The symptoms of retinoblastoma can vary depending on the size and location of the tumor. Common signs include:

• Leukocoria (White Reflex): A white reflection or “white eye” seen in photographs where the pupil should appear black. This is often the first noticeable sign, and it occurs when light is reflected off the tumor in the back of the eye.
• Strabismus (Crossed Eyes): Misalignment of the eyes, which may occur if the tumor affects the muscles or nerves controlling eye movement.
• Vision Problems: Difficulty seeing, poor vision, or in some cases, total blindness in the affected eye.
• Redness or Inflammation: A red, inflamed, or swollen eye due to tumor growth or secondary inflammation.
• Pain: In advanced cases, pain in or around the eye may develop.

Diagnosis of Retinoblastoma

Retinoblastoma is often diagnosed during routine pediatric eye exams or when parents notice unusual signs, such as a white pupil in photographs. Diagnosis involves a thorough eye examination and a series of tests, including:

1. Fundus Examination:
   • An ophthalmologist will dilate the child’s pupils and examine the retina for any abnormal growths or tumors.
2. Imaging Tests:
   • Ultrasound: A retinal ultrasound is used to visualize the size and location of the tumor.
   • CT scan and MRI: These imaging techniques can help determine the extent of the tumor and whether it has spread to other parts of the eye or surrounding tissues.
3. Genetic Testing:
   • In cases of hereditary retinoblastoma, genetic testing may be conducted to identify mutations in the RB1 gene, which may also inform about the risk to other family members.
4. Biopsy:
   • A biopsy is typically not required because the diagnosis can be confirmed through imaging and genetic testing, but it may be done in rare, ambiguous cases.

Treatment of Retinoblastoma

Treatment of retinoblastoma depends on the size, location, and stage of the tumor, as well as whether one or both eyes are affected. The goal of treatment is to remove or destroy the tumor while preserving vision if possible. Options include:

1. Enucleation (Surgical Removal of the Eye):
   • In cases where the tumor is large, involves the optic nerve, or is unresponsive to other treatments, the affected eye may need to be surgically removed to prevent the spread of cancer. Enucleation is common in cases of advanced retinoblastoma and is usually followed by prothesis (artificial eye) fitting.
2. Chemotherapy:
   • Systemic chemotherapy is commonly used to shrink the tumor, particularly in cases of bilateral retinoblastoma or when the tumor is inoperable. Drugs such as vincristine, carboplatin, and etoposide are often used. Chemotherapy may also be combined with other therapies like laser therapy or cryotherapy.
3. Laser Therapy (Photocoagulation):
   • Laser therapy is used to treat smaller tumors or tumors located near the periphery of the retina. The laser is directed at the tumor to destroy it or shrink it, and it is usually performed under general anesthesia.
4. Cryotherapy (Freezing Treatment):
   • Cryotherapy uses extreme cold to destroy the tumor. It is particularly useful for tumors located in the peripheral retina.
5. Radiation Therapy:
   • External beam radiation may be used for tumors that cannot be treated with surgery or chemotherapy, although it is typically reserved for cases where other treatments have failed. Radiation may be used to treat the whole eye or just the tumor itself.
6. Intra-arterial Chemotherapy:
   • In some cases, chemotherapy is delivered directly to the eye via the ophthalmic artery to target the tumor more directly and reduce systemic side effects.
7. Brachytherapy:
   • This treatment involves the placement of a radioactive implant near the tumor to destroy cancer cells. It is typically used for localized tumors.

Prognosis

The prognosis for children with retinoblastoma depends on several factors, including the stage of the disease at diagnosis, whether one or both eyes are affected, and how well the tumor responds to treatment.

• Early detection and treatment are key to successful outcomes. When diagnosed early, the survival rate for retinoblastoma is over 95%.
• For hereditary retinoblastoma, children may require genetic counseling, as they have a higher risk of developing other cancers in adulthood, such as osteosarcoma or melanoma.
• Vision preservation depends on the tumor’s size and location. In some cases, particularly with small, localized tumors, vision in the affected eye can be preserved through treatments like laser therapy and cryotherapy.

Long-Term Follow-Up and Survivorship

Children who survive retinoblastoma require long-term follow-up to monitor for potential recurrence of the tumor or development of secondary cancers, especially in hereditary cases. Regular eye exams and imaging studies are essential to catch any changes early. Families may also be referred for genetic counseling to assess the risk of passing the condition on to future generations.

Conclusion

Retinoblastoma, though rare, is a highly treatable form of childhood cancer. Early diagnosis, typically facilitated by leukocoria (white reflex in the eye), and advances in treatment techniques, including chemotherapy, laser therapy, and surgery, have significantly improved survival rates. While the disease can pose serious challenges, including the potential loss of vision and risk of secondary cancers, the prognosis for most children with retinoblastoma is very favorable when the condition is caught and treated early.

Advancements in research and treatment continue to improve outcomes, and ongoing genetic studies may help further reduce the risks for affected families.